|Subscribe to our YouTubeChannel||
Prime Minister Narendra Modi said Sunday’s approval of AstraZeneca-Oxford vaccines manufactured in India by the Serum Institute of India (SII) and Bharat Biotech Ltd has accelerated the road to a healthier and The Drug Controller General of India (DCGI) was noticed just a few minutes after two emergency shots. The Prime Minister also expressed his appreciation to the frontline
A decisive turning point for a spirited fight to be strengthened! DCGI’s approval of @SerumInstIndia and @BharatBiotech medications tends to boost the path to a healthier COVID-free country. Well, congratulations to India. Congratulations to our hard-working scientific and technical information,’ PM Modi said. Every Indian would be proud that the two vaccines that were approved for emergency use were made in India! This demonstrates our scientific community’s eagerness to fulfil the dream of an Aatmanirbhar Bharat, at the root of which he said is care and compassion.
A decisive turning point to strengthen a spirited fight!
Congratulations to our hardworking scientists and innovators.
— Narendra Modi (@narendramodi) January 3, 2021
We would like to reiterate our gratitude to the doctors, the medical staff, the scientists, the police, the sanitation staff, and all the Corona warriors for the excellent work they have done, except in adverse circumstances. We will continue to stay grateful to them forever for protecting many human life,’ he added.
The Prime Minister’s tweet came after India’s Drug Controller General VG Somani formally announced the approval of two coronavirus vaccines for emergency use, one developed by AstraZeneca and Oxford University, and the other by Bharat Biotech, a local company. “Somani during a press conference, “CDSCO (Central Drugs Standard Control Organisation) accepts the subject of expert committee reform rations on Serum and Bharat Biotech Covid vaccines. Somani read from a written statement that “M/s Serum and M/s Bharat Biotech vaccines are approved for limited use in emergency situations.”
The overall efficacy of the AstraZeneca-Oxford vaccine was 70.42 percent and that of Covaxin from Bharat Biotech was “safe and provides a robust immune response,” Somani said. If there is the slightest safety concern, we will never approve anything. The vaccines are safe at 100 percent. “For every vaccine, some harmful effects such as mild headache, sadness, and allergic skin reactions are common,” he added.
The Oxford-AstraZeneca vaccine, which is manufactured by the Serum Institute of India (SII) as Covishield for emergency use and Covaxin for limited use, was recommended by the Subject Expert Committee (SEC) under CDSCO. Covaxin is an indigenous vaccine developed in collaboration with the Indian Council of Agricultural Research by Bharat Biotech (ICMR).